Zuzanna Brzosko, George Foot and Anna Perdrix Rosell
Sixfold Bioscience
Brzosko, 28, Foot, 29, and Perdrix Rosell, 27, are developing technology to deliver high doses of medication direct to tumours, rather than affecting the healthy cells of cancer patients. The trio, based at Imperial College London’s start-up incubator, have started lab tests on mice.
